Endogenous stimulus-responsive nitric oxide releasing bioactive liposome for a multilayered drug-eluting balloon
Open Access
- 8 December 2022
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 11 (3) , 916-930
Abstract
Drug-eluting balloon (DEB) system has been widely utilized for percutaneous coronary intervention (PCI), treating atherosclerosis to overcome the limitations of cardiovascular stents. With the anti-proliferative drug, everolimus (EVL), nitric oxide (NO) plays a key bioregulator role to facilitate the angiogenesis of endothelial cells (ECs) and inhibit the cell proliferation of smooth muscle cells (SMCs) in the lesions of cardiovascular diseases. Due to the very short lifetime and limited exposure area of NO in the body, the continuous release and efficient delivery of NO must be carefully considered. In this respect, a liposome-containing disulfide bonding group was introduced as a delivery vehicle of EVL and NO with the continuous release of NO via successive reaction cycles with GSH and SNAP in the blood vessel without the need for exogenous stimulations. With a multilayer coating platform consisting of a polyvinylpyrrolidone (PVP)/EVL-laden liposome with NO (EVL-NO-Lipo)/PVP, we precluded the loss of the EVL-encapsulated liposome with NO release during the transition time and maximized the transfer rate from the surface of DEB to the tissues. The sustained release of NO was monitored using a nitric oxide analyzer (NOA), and the synergistic bioactivities of EVL and NO were proved in EC and SMC with angiogenesis and cell proliferation-related assays. From the results of hemocompatibility and ex vivo studies, the feasibility was provided for future in vivo applications of the multilayer-coated DEB system.Keywords
Funding Information
- Ministry of Science and ICT, South Korea (2018M3A9E2024579, 202011A05-05, 2020R1A2B5B03002344, 2022R1I1A1A01068486)
This publication has 55 references indexed in Scilit:
- Drug eluting stents: Developments and current statusJournal of Controlled Release, 2012
- Nitric Oxide Mediates the Stress Response Induced by Diatom Aldehydes in the Sea Urchin Paracentrotus lividusPLOS ONE, 2011
- The relationship between platelet adhesion on surfaces and the structure versus the amount of adsorbed fibrinogenBiomaterials, 2010
- Nitric oxide: new evidence for novel therapeutic indicationsExpert Opinion on Pharmacotherapy, 2008
- Pathophysiology of Coronary Artery DiseaseCirculation, 2005
- Nitric oxide and arterial diseaseJournal of Vascular Surgery, 2004
- Vascular effects of environmental oestrogens: implications for reproductive and vascular healthHuman Reproduction Update, 2000
- Nitric oxide–an endothelial cell survival factorCell Death & Differentiation, 1999
- Activation of Platelets in Platelet-Rich Plasma by Rotablation Is Speed-Dependent and Can Be Inhibited by Abciximab (c7E3 Fab; ReoPro)Circulation, 1998
- Does Nitric Oxide Regulate Smooth Muscle Cell Proliferation?Journal of Vascular Research, 1998